The Stanford Neuro-Oncology Program News and Events
Three types of cells in the brain’s white matter show interwoven problems during the cognitive dysfunction that follows treatment with the cancer drug methotrexate, Stanford neuroscientists have found.
Guided by Reena Thomas, MD, PhD, clinical assistant professor of neurology and neurological sciences and of neurosurgery, second-year medical student Judith Pelpola investigated therapies to reduce the recurrence of glioblastoma.
The Riley Church Guest Professor
Scott Pomeroy, MD, PhD
Neurologist-in-Chief , Boston Children’s Hospital
"Heterogeneity of Molecular Mechanisms in Subgroups of Medulloblastoma”
Thursday November 29, 2018 at 1:00pm
Location: Lokey G1002
Cancer Biology Seminar Series
Mario Suva, MD, PhD
Harvard Medical School
Massachusetts General Hospital
"Dissecting Pediatric and Adult Gliomas by Single-cell Genomics"
March 5, 2019 • 12-1pm
Location: Clark Center Auditorium
Grants and Awards
2018 NIH Director’s Pioneer Award
Michelle Monje, MD, PhD is a 2018 Awardee of the NIH Director’s Pioneer Award. The Pioneer Award supports individual scientists of exceptional creativity who propose highly innovative and potentially transformative approaches to major challenges in the biomedical or behavioral sciences towards the goal of enhancing human health. Dr. Monje received the award based on her laboratory research which discovered that neuronal activity critically regulates the progression of glial malignancies, and now seeks to leverage a deeper understanding of neuron-glioma interactions to develop novel therapeutic strategies for these lethal brain cancers.
23rd ANNUAL SCIENTIFIC MEETING AND EDUCATION DAY
OF THE SOCIETY FOR NEURO-ONCOLOGY
Marriott Hotel, New Orleans, Louisiana
Thursday, November 15 - Sunday, November 18, 2018